During the past decade, Providence Oncology and Hematology Care Clinic - Westside conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Oncology and Hematology Care Clinic - Westside" #1 sponsor was "Bristol-Myers Squibb" with 5 trials, followed by "Pfizer" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Providence Health & Services" with 3 trials sponsored and "Dendreon" with 3 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Oncology and Hematology Care Clinic - Westside" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "BioNTech SE" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Providence Oncology and Hematology Care Clinic - Westside" are "Melanoma" (3 trials), "Breast Cancer" (2 trials), "Advanced Prostate Cancer" (1 trials), "Advanced Solid Tumor" (1 trials) and "Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial" (1 trials). Many other conditions were trialed in "Providence Oncology and Hematology Care Clinic - Westside" in a lesser frequency.

Most popular intervention types in "Providence Oncology and Hematology Care Clinic - Westside" are "Drug" (17 trials), "Biological" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (2 trials), "Nivolumab" (2 trials), "sipuleucel-T" (2 trials), "12 mg/kg α-TEA" (1 trials) and "16.8 mg/kg α-TEA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Providence Oncology and Hematology Care Clinic - Westside" are 17 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Providence Oncology and Hematology Care Clinic - Westside". undefined are not yet recruiting, 3 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Providence Oncology and Hematology Care Clinic - Westside, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Oncology and Hematology Care Clinic - Westside, 8 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".